KBC Group’s Axogen AXGN Stock Holding History

KBC Group’s Portfolio AXGN Stock Details AXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$57K	Hold	1,243	–	–	﹤0.01%	1665
2026 Q1	$41K	Buy	+1,243	New	+$40.4K	﹤0.01%	1720

Other funds holding AXGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

KBC Group's AXGN Position: Q2 2026 in Review

KBC Group held its Axogen (AXGN) position steady in Q2 2026 at 1,243 shares worth $57K. The position accounts for ﹤0.01% of the portfolio, ranked #1665.

KBC Group first reported a position in AXGN in Q1 2026 and has held it in 2 quarters since. 254 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

KBC Group held 1,243 shares of Axogen worth $57K as of Q2 2026.
KBC Group left its Axogen share count unchanged in Q2 2026.
Axogen made up ﹤0.01% of KBC Group's portfolio in Q2 2026, its #1665 holding.
KBC Group first reported a position in Axogen in Q1 2026 and has held it in 2 quarters since.
254 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on KBC Group's 13F filing for Q2 2026, filed 5 Aug 2026.